Eclipse Regenesis, Inc. has developed the first restorative therapy to address Short Bowel Syndrome (SBS), a malabsorption disorder caused by a lack of functional small intestine.

www.ensorelief.comNon invasive neuromodulation for chronic pain management.

- NivaSonix- Spiritus- Domain Surgical- Invuity

- Participated in raising a seed round private financing- General management of all aspects of the business- Drove the development from concept to functional prototype- Developed business plan and commercialization strategy- Established operating systems including regulatory, quality, finance, R&D, legal

• Great Point Partners, LLC - market research, technology assessment, business plan development• Orchard Capital Corp - market research, technology assessment, business plan development• Ice-Grip.com - branding, marketing, media, and commercialization

• Created and drove commercialization plan that produced significant first year revenue • Participated in raising a $26M Series C private financing • Drove global physician awareness and clinical credibility of a novel stroke reduction therapy (percutaneous left atrial appendage closure)• Built Scientific Advisory Board consisting of world renowned Electrophysiologists and Interventional Cardiologists• Led all marketing, branding, positioning, messaging and communications• Implemented sales tracking, reporting, and management systems

• Officer of the company that drove PEAK Surgical from concept to $120M sale to Medtronic in five years• Participated in raising a $21M Series C private financing• Led global marketing, clinical affairs, and international sales which contributed 25% of annual sales• Drove rapid product sales growth: FY1: $4M, FY2: $17M, FY3: $30M (est.)• Designed the brand from inception including marketing and communications • Created and drove the clinical and preclinical affairs programs to support all regulatory filings and marketing performance claims• Spearheaded surgeon and market input for all product development• Built multidisciplinary Scientific Advisory Board (orthopedic, general, plastic, and electrophysiology)• Led efforts to determine key surgical specialties to target via internal and external qualitative and quantitative market research

• Senior member of the Sports Medicine business unit responsible for managing all areas of global marketing, clinical and product strategies• Grew US Opus and Atlantech sales by 200%+ from 2004 to 2005• Led Opus Medical and Atlantech Medical post acquisition integrations • Managed $100M+ global sports medicine Coblation business with 20%+ annual growth

Managed all marketing and communications across 25 countries.Doubled international sports medicine distributor sales from $12M to $24M in one year.Established international Scientific Advisory Board and Speakers Bureau.

Created and launched new business unit focused on skin resurfacing.Executed market and practice development programs.